basal-bolus insulin ratio

The appropriate basal-bolus insulin ratio for effective blood glucose management generally involves allocating approximately 50% of the total daily insulin dose (TDD) to basal insulin and the remaining 50% to bolus insulin distributed around meals. This is the typical starting point in clinical practice, with subsequent adjustments based on individual patient needs, lifestyle, glycemic targets, and risk of hypoglycaemia.

In adults with type 2 diabetes, basal insulin (such as NPH insulin, insulin detemir, or insulin glargine) is usually initiated and titrated first to target fasting plasma glucose, often comprising about half of the TDD. When basal insulin alone does not achieve glycemic targets, short-acting insulin is added before meals in a basal-bolus regimen, with bolus insulin accounting for the remaining approximate half of the TDD NICE CKS,NICE CKS,NICE NG28.

Clinical protocols often split the bolus insulin dose unequally across meals, commonly with 20% before breakfast and 40% each before lunch and dinner, reflecting typical dietary patterns and circadian glucose variations Chen et al. 2025.

The basal-bolus regimen offers the greatest flexibility to mimic physiological insulin patterns, providing basal insulin to cover endogenous basal needs and bolus insulin to manage postprandial excursions NICE CKS,NICE CKS,NICE NG28.

In the context of acute or hospital settings, individualized basal-bolus insulin dosing based on insulin infusion studies often results in basal insulin constituting approximately 55% of TDD and bolus insulin 45%, slightly shifting the ratio to provide more basal insulin in insulin-resistant states or during glucocorticoid therapy (e.g., prednisolone-associated hyperglycaemia) Chen et al. 2025.

Automated insulin delivery systems and basal-bolus therapy protocols frequently estimate basal insulin as 50-60% of TDD, with bolus and correction doses making up the rest, aligning with the standard basal-bolus proportions in manual regimens. These systems tailor dose adjustments dynamically and can adjust basal insulin flexibly to meet individual glycemic patterns Shah et al. 2026.

In type 1 diabetes, basal-bolus insulin therapy is standard, with basal insulin typically covering 40-60% of insulin requirements, and bolus insulin covering 40-60% distributed across meals, with individualization taking into account activity levels, meal content, and glucose monitoring NICE CKS,NICE NG17.

Overall, the basal-bolus insulin ratio is not fixed and should be individualized, but a starting approximation of basal insulin as 50% of TDD and bolus insulin as 50% divided among meals is appropriate and widely supported by UK guidelines and international literature.